Compound ID | 2686
Class: Natural product antibiotic
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae, Lactobacillus casei, Mycobacterium bovis, and Mycobacterium fortuitum |
| Propensity to select resistant mutants: | Develops rapidly (in vitro assay with Staphylococcus aureus) |
| Description: | Natural product from Streptomyces prasinus; only effective against growing cells; active only against growing cells; protects mice from Streptococcus infection only when administered subcutaneously and not orally; shows prophylactic action (vs. Staphylococcus infection in mice) |
| Institute where first reported: | Squibb Institute for Medical Research, New Brunswick, New Jersey 08903 USA |
| Year first mentioned: | 1968 |
| Development status: | Experimental |